OAB-14 is a Bexarotene derivative that improves Alzheimer's disease-related pathology and cognitive impairment by enhancing β-amyloid clearance in APP/PS1 mice; it effectively ameliorates dysfunction of the endosomal-autophagic-lysosomal pathway in APP/PS1 transgenic mice.